{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:09:14Z","timestamp":1790899754179,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003495","name":"Hessisches Ministerium f\u00fcr Wissenschaft und Kunst","doi-asserted-by":"publisher","award":["llL5\u2010518\/17.004"],"award-info":[{"award-number":["llL5\u2010518\/17.004"]}],"id":[{"id":"10.13039\/501100003495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70112587"],"award-info":[{"award-number":["70112587"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.15252\/emmm.201809158","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T05:55:11Z","timestamp":1537163711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":210,"title":["In vivo generation of human CD19\u2010CAR T cells results in B\u2010cell depletion and signs of cytokine release syndrome"],"prefix":"10.1038","volume":"10","author":[{"given":"Anett","family":"Pfeiffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic B","family":"Thalheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika M","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben R","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Danisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried S","family":"Wels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Modlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Stripecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Verhoeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9837-7345","authenticated-orcid":false,"given":"Christian J","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"key":"BFEMMM201809158_CR1","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1182\/blood-2012-11-468579","volume":"122","author":"T Abel","year":"2013","unstructured":"Abel T, El Filali E, Waern J, Schneider IC, Yuan Q, M\u00fcnch RC, Hick M, Warnecke G, Madrahimov N, Kontermann RE et\u00a0al (2013) Specific gene delivery to liver sinusoidal and artery endothelial cells. Blood 122: 2030\u20132038","journal-title":"Blood"},{"key":"BFEMMM201809158_CR2","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2013-11-540641","volume":"123","author":"F Amirache","year":"2014","unstructured":"Amirache F, Levy C, Costa C, Mangeot P\u2010E, Torbett BE, Wang CX, Negre D, Cosset F\u2010L, Verhoeyen E (2014) Mystery solved: VSV\u2010G\u2010LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. Blood 123: 1422\u20131424","journal-title":"Blood"},{"key":"BFEMMM201809158_CR3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nmeth.1514","volume":"7","author":"B Anliker","year":"2010","unstructured":"Anliker B, Abel T, Kneissl S, Hlavaty J, Caputi A, Brynza J, Schneider IC, M\u00fcnch RC, Petznek H, Kontermann RE et\u00a0al (2010) Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nat Methods 7: 929\u2013935","journal-title":"Nat Methods"},{"key":"BFEMMM201809158_CR4","doi-asserted-by":"crossref","first-page":"e1005641","DOI":"10.1371\/journal.ppat.1005641","volume":"12","author":"RR Bender","year":"2016","unstructured":"Bender RR, Muth A, Schneider IC, Friedel T, Hartmann J, Pluckthun A, Maisner A, Buchholz CJ (2016) Receptor\u2010targeted Nipah virus glycoproteins improve cell\u2010type selective gene delivery and reveal a preference for membrane\u2010proximal cell attachment. PLoS Pathog 12: e1005641","journal-title":"PLoS Pathog"},{"key":"BFEMMM201809158_CR5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tibtech.2015.09.008","volume":"33","author":"CJ Buchholz","year":"2015","unstructured":"Buchholz CJ, Friedel T, B\u00fcning H (2015) Surface\u2010engineered viral vectors for selective and cell type\u2010specific gene delivery. Trends Biotechnol 33: 777\u2013790","journal-title":"Trends Biotechnol"},{"key":"BFEMMM201809158_CR6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1182\/blood-2003-01-0297","volume":"102","author":"S Cavalieri","year":"2003","unstructured":"Cavalieri S, Cazzaniga S, Geuna M, Magnani Z, Bordignon C, Naldini L, Bonini C (2003) Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 102: 497\u2013505","journal-title":"Blood"},{"key":"BFEMMM201809158_CR7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/14712598.2015.1046430","volume":"15","author":"M Chmielewski","year":"2015","unstructured":"Chmielewski M, Abken H (2015) TRUCKs: the fourth generation of CARs. Expert Opin Biol Ther 15: 1145\u20131154","journal-title":"Expert Opin Biol Ther"},{"key":"BFEMMM201809158_CR8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ymthe.2017.01.011","volume":"25","author":"I Diaconu","year":"2017","unstructured":"Diaconu I, Ballard B, Zhang M, Chen Y, West J, Dotti G, Savoldo B (2017) Inducible Caspase\u20109 selectively modulates the toxicities of CD19\u2010specific chimeric antigen receptor\u2010modified T cells. Mol Ther 25: 580\u2013592","journal-title":"Mol Ther"},{"key":"BFEMMM201809158_CR9","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1182\/blood-2008-05-155945","volume":"112","author":"C Frecha","year":"2008","unstructured":"Frecha C, Costa C, Negre D, Gauthier E, Russell SJ, Cosset F\u2010L, Verhoeyen E (2008) Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins. Blood 112: 4843\u20134852","journal-title":"Blood"},{"key":"BFEMMM201809158_CR10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/scd.2015.0386","volume":"25","author":"T Friedel","year":"2016","unstructured":"Friedel T, Jung\u2010Klawitter S, Sebe A, Schenk F, Modlich U, Ivics Z, Schumann GG, Buchholz CJ, Schneider IC (2016) CD30 receptor\u2010targeted lentiviral vectors for human induced pluripotent stem cell\u2010specific gene modification. Stem Cells Dev 25: 729\u2013739","journal-title":"Stem Cells Dev"},{"key":"BFEMMM201809158_CR11","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.15252\/emmm.201607485","volume":"9","author":"J Hartmann","year":"2017","unstructured":"Hartmann J, Sch\u00fc\u00dfler\u2010Lenz M, Bondanza A, Buchholz CJ (2017) Clinical development of CAR T cells \u2010 challenges and opportunities in translating innovative treatment concepts. EMBO Mol Med 9: 1183\u20131197","journal-title":"EMBO Mol Med"},{"key":"BFEMMM201809158_CR12","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","volume":"130","author":"KA Hay","year":"2017","unstructured":"Hay KA, Hanafi L\u2010A, Li D, Gust J, Liles WC, Wurfel MM, L\u00f3pez JA, Chen J, Chung D, Harju\u2010Baker S et\u00a0al (2017) Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor\u2010modified T cell therapy. Blood 130: 2295\u20132306","journal-title":"Blood"},{"key":"BFEMMM201809158_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fimmu.2017.00267","volume":"8","author":"M Irving","year":"2017","unstructured":"Irving M, Vuillefroy de Silly R, Scholten K, Dilek N, Coukos G (2017) Engineering chimeric antigen receptor T\u2010cells for racing in solid tumors: don't forget the fuel. Front Immunol 8: 267","journal-title":"Front Immunol"},{"key":"BFEMMM201809158_CR14","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June CH, O'Connor RS, Kawalekar OU, Ghassemi S, Milone MC (2018) CAR T cell immunotherapy for human cancer. Science 359: 1361\u20131365","journal-title":"Science"},{"key":"BFEMMM201809158_CR15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2016.12.006","volume":"4","author":"BL Levine","year":"2017","unstructured":"Levine BL, Miskin J, Wonnacott K, Keir C (2017) Global manufacturing of CAR T cell therapy. Mol Ther Methods Clin Dev 4: 92\u2013101","journal-title":"Mol Ther Methods Clin Dev"},{"key":"BFEMMM201809158_CR16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","volume":"168","author":"WA Lim","year":"2017","unstructured":"Lim WA, June CH (2017) The principles of engineering immune cells to treat cancer. Cell 168: 724\u2013740","journal-title":"Cell"},{"key":"BFEMMM201809158_CR17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6750-10-16","volume":"10","author":"E Lobbestael","year":"2010","unstructured":"Lobbestael E, Reumers V, Ibrahimi A, Paesen K, Thiry I, Gijsbers R, van den Haute C, Debyser Z, Baekelandt V, Taymans J\u2010M (2010) Immunohistochemical detection of transgene expression in the brain using small epitope tags. BMC Biotechnol 10: 16","journal-title":"BMC Biotechnol"},{"key":"BFEMMM201809158_CR18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.aah6192","volume":"353","author":"L Naldini","year":"2016","unstructured":"Naldini L, Trono D, Verma IM (2016) Lentiviral vectors, two decades later. Science 353: 1101\u20131102","journal-title":"Science"},{"key":"BFEMMM201809158_CR19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","volume":"24","author":"M Norelli","year":"2018","unstructured":"Norelli M, Camisa B, Barbiera G, Falcone L, Purevdorj A, Genua M, Sanvito F, Ponzoni M, Doglioni C, Cristofori P et\u00a0al (2018) Monocyte\u2010derived IL\u20101 and IL\u20106 are differentially required for cytokine\u2010release syndrome and neurotoxicity due to CAR T cells. Nat Med 24: 739\u2013748","journal-title":"Nat Med"},{"key":"BFEMMM201809158_CR20","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/ijc.30217","volume":"139","author":"S Oelsner","year":"2016","unstructured":"Oelsner S, Wagner J, Friede ME, Pfirrmann V, Genssler S, Rettinger E, Buchholz CJ, Pfeifer H, Schubert R, Ottmann OG et\u00a0al (2016) Chimeric antigen receptor\u2010engineered cytokine\u2010induced killer cells overcome treatment resistance of pre\u2010B\u2010cell acute lymphoblastic leukemia and enhance survival. Int J Cancer 139: 1799\u20131809","journal-title":"Int J Cancer"},{"key":"BFEMMM201809158_CR21","doi-asserted-by":"crossref","first-page":"303ra139","DOI":"10.1126\/scitranslmed.aac5415","volume":"7","author":"DL Porter","year":"2015","unstructured":"Porter DL, Hwang W\u2010T, Frey NV, Lacey SF, Shaw PA, Loren AW, Bagg A, Marcucci KT, Shen A, Gonzalez V et\u00a0al (2015) Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl Med 7: 303ra139","journal-title":"Sci Transl Med"},{"key":"BFEMMM201809158_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aaj2013","volume":"9","author":"W Qasim","year":"2017","unstructured":"Qasim W, Zhan H, Samarasinghe S, Adams S, Amrolia P, Stafford S, Butler K, Rivat C, Wright G, Somana K et\u00a0al (2017) Molecular remission of infant B\u2010ALL after infusion of universal TALEN gene\u2010edited CAR T cells. Sci Transl Med 9: 1\u20138","journal-title":"Sci Transl Med"},{"key":"BFEMMM201809158_CR23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ymthe.2017.03.034","volume":"25","author":"I Riviere","year":"2017","unstructured":"Riviere I, Sadelain M (2017) Chimeric antigen receptors: a cell and gene therapy perspective. Mol Ther 25: 1117\u20131124","journal-title":"Mol Ther"},{"key":"BFEMMM201809158_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.cji.0000210386.55951.c2","volume":"29","author":"SA Rosenberg","year":"2006","unstructured":"Rosenberg SA, Sport\u00e8s C, Ahmadzadeh M, Fry TJ, Ngo LT, Schwarz SL, Stetler\u2010Stevenson M, Morton KE, Mavroukakis SA, Morre M et\u00a0al (2006) IL\u20107 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T\u2010regulatory cells. J Immunother 29: 313\u2013319","journal-title":"J Immunother"},{"key":"BFEMMM201809158_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-319-42934-2_2","volume":"209","author":"A Schambach","year":"2016","unstructured":"Schambach A, Morgan M (2016) Retroviral vectors for cancer gene therapy. Recent Results Cancer Res 209: 17\u201335","journal-title":"Recent Results Cancer Res"},{"key":"BFEMMM201809158_CR26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nnano.2017.57","volume":"12","author":"TT Smith","year":"2017","unstructured":"Smith TT, Stephan SB, Moffett HF, McKnight LE, Ji W, Reiman D, Bonagofski E, Wohlfahrt ME, Pillai SPS, Stephan MT (2017) In situ programming of leukaemia\u2010specific T cells using synthetic DNA nanocarriers. Nat Nanotechnol 12: 813\u2013820","journal-title":"Nat Nanotechnol"},{"key":"BFEMMM201809158_CR27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2015.247","volume":"30","author":"D Sommermeyer","year":"2016","unstructured":"Sommermeyer D, Hudecek M, Kosasih PL, Gogishvili T, Maloney DG, Turtle CJ, Riddell SR (2016) Chimeric antigen receptor\u2010modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in\u00a0vivo. Leukemia 30: 492\u2013500","journal-title":"Leukemia"},{"key":"BFEMMM201809158_CR28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2015.06.006","volume":"62","author":"K Sonntag","year":"2015","unstructured":"Sonntag K, Eckert F, Welker C, M\u00fcller H, M\u00fcller F, Zips D, Sipos B, Klein R, Blank G, Feuchtinger T et\u00a0al (2015) Chronic graft\u2010versus\u2010host\u2010disease in CD34(+)\u2010humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease. J Autoimmun 62: 55\u201366","journal-title":"J Autoimmun"},{"key":"BFEMMM201809158_CR29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","volume":"16","author":"S Stein","year":"2010","unstructured":"Stein S, Ott MG, Schultze\u2010Strasser S, Jauch A, Burwinkel B, Kinner A, Schmidt M, Kramer A, Schwable J, Glimm H et\u00a0al (2010) Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16: 198\u2013204","journal-title":"Nat Med"},{"key":"BFEMMM201809158_CR30","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ajpath.2017.02.015","volume":"187","author":"B Sundarasetty","year":"2017","unstructured":"Sundarasetty B, Volk V, Theobald SJ, Rittinghausen S, Schaudien D, Neuhaus V, Figueiredo C, Schneider A, Gerasch L, Mucci A et\u00a0al (2017) Human effector memory T helper cells engage with mouse macrophages and cause graft\u2010versus\u2010host\u2010like pathology in skin of humanized mice used in a nonclinical immunization study. Am J Pathol 187: 1380\u20131398","journal-title":"Am J Pathol"},{"key":"BFEMMM201809158_CR31","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.4049\/jimmunol.176.11.6702","volume":"176","author":"L Swainson","year":"2006","unstructured":"Swainson L, Verhoeyen E, Cosset F\u2010L, Taylor N (2006) IL\u20107R gene expression is inversely correlated with cell cycle progression in IL\u20107\u2010stimulated T lymphocytes. J Immunol 176: 6702\u20136708","journal-title":"J Immunol"},{"key":"BFEMMM201809158_CR32","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.4049\/jimmunol.1103660","volume":"188","author":"S Tanaka","year":"2012","unstructured":"Tanaka S, Saito Y, Kunisawa J, Kurashima Y, Wake T, Suzuki N, Shultz LD, Kiyono H, Ishikawa F (2012) Development of mature and functional human myeloid subsets in hematopoietic stem cell\u2010engrafted NOD\/SCID\/IL2r\u03b3KO mice. J Immunol 188: 6145\u20136155","journal-title":"J Immunol"},{"key":"BFEMMM201809158_CR33","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2002-07-2224","volume":"101","author":"E Verhoeyen","year":"2003","unstructured":"Verhoeyen E, Dardalhon V, Ducrey\u2010Rundquist O, Trono D, Taylor N, Cosset F\u2010L (2003) IL\u20107 surface\u2010engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 101: 2167\u20132174","journal-title":"Blood"},{"key":"BFEMMM201809158_CR34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev-pathol-052016-100332","volume":"12","author":"NC Walsh","year":"2017","unstructured":"Walsh NC, Kenney LL, Jangalwe S, Aryee K\u2010E, Greiner DL, Brehm MA, Shultz LD (2017) Humanized mouse models of clinical disease. Annu Rev Pathol 12: 187\u2013215","journal-title":"Annu Rev Pathol"},{"key":"BFEMMM201809158_CR35","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1182\/blood-2012-02-412973","volume":"120","author":"Q Zhou","year":"2012","unstructured":"Zhou Q, Schneider IC, Edes I, Honegger A, Bach P, Sch\u00f6nfeld K, Schambach A, Wels WS, Kneissl S, Uckert W et\u00a0al (2012) T\u2010cell receptor gene transfer exclusively to human CD8(+) cells enhances tumor cell killing. Blood 120: 4334\u20134342","journal-title":"Blood"},{"key":"BFEMMM201809158_CR36","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.4049\/jimmunol.1500956","volume":"195","author":"Q Zhou","year":"2015","unstructured":"Zhou Q, Uhlig KM, Muth A, Kimpel J, L\u00e9vy C, M\u00fcnch RC, Seifried J, Pfeiffer A, Trkola A, Coulibaly C et\u00a0al (2015) Exclusive transduction of human CD4+ T cells upon systemic delivery of CD4\u2010targeted lentiviral vectors. J Immunol 195: 2493\u20132501","journal-title":"J Immunol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201809158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.201809158","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.201809158\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.201809158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.201809158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:28:57Z","timestamp":1779085737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.201809158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11,1]]}},"alternative-id":["BFEMMM201809158"],"URL":"https:\/\/doi.org\/10.15252\/emmm.201809158","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734036173.793581845","asserted-by":"object"}]},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,17]]},"assertion":[{"value":"25 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.B., E.V., and C.J.B are listed as inventors on a patent covering the CD8\u2010targeted lentiviral vector. All other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"EMMM201809158"}}